The EPS projection of Globus Medical, Inc. (NYSE:GMED) for quarter ended 2016-09-30 is $0.3. A week before, the EPS forecast was $0.3 against target of $0.3, a month earlier. This estimate stood at $0.3 60 days earlier versus forecast of $0.3 90 days earlier, confirming a deviation of 0%.
Globus Medical, Inc. (NYSE:GMED) reported that 18 days ago, the positive EPS revisions were 2 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Globus Medical, Inc. (NYSE:GMED) in the preceding 120, 60, 30 and 90 days were 2, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Globus Medical, Inc. (NYSE:GMED) was $0.3. This projection was computed after accounting 7 calls. As reported on 2016-05-03 the EPS was $0.29. The change was $0.01, demonstrating a percentage deviation of 3.57%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Globus Medical, Inc. (NYSE:GMED) stands at $155.233 and the median estimate at $155.2. Almost 3 analysts announced their estimates.
The highest estimate is $156.3 while the lowest target is $154.2 showing standard deviation of 1.05%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. Globus Medical, Inc. (NYSE:GMED) stated that the change in forecast was 0.441%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...